Tag: Data Safety Monitoring Board

October 9, 2019

IntelGenx Receives DSMB Recommendation for Phase 2a Trial

The Data Safety Monitoring Board completed its analysis of the company's Montelukast VersaFilm Phase 2a clinical trial of Alzheimer's Disease.